Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients
Clinical trial NCT03369704 · COMPLETED
Trial details
- NCT number
- NCT03369704
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2018-05-11
- Enrollment
- 337
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.